BriaCell Therapeutics Corp (TSX:BCT) Financings

BriaCell Therapeutics Corp

Financings

RaiseDate
Public offering of units (one common share or pre-funded warrant and one warrant)
Closed: US$30M raised · US$5.59 a unit · 1 warrant at US$6.93 for 60 months · ThinkEquity
Dealers: ThinkEquity (lead)
Use of proceeds: Working capital, general corporate purposes and advancing the company's business objectives
Jan 15, 2026
Public offering of units (one common share or pre-funded warrant and one warrant)
Closed: US$15M raised · US$1.25 a unit · 1 warrant at US$1.5 for 60 months · ThinkEquity
Dealers: ThinkEquity (lead)
Use of proceeds: Working capital, general corporate purposes and advancing business objectives
Jul 16, 2025
Public offering of units (one common share or pre-funded warrant and one warrant)
Closed: US$13.8M raised · US$4.5 a unit · 1 warrant at US$5.25 for 60 months · ThinkEquity
Dealers: ThinkEquity (lead)
Use of proceeds: Working capital, general corporate purposes and advancement of business objectives
Apr 28, 2025

Read by 6ix AI from the company's releases